TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
AstraZeneca AB
Closing information (x1000 SEK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
165,242,000
|
114,063,000
|
107,280,000 |
| Financial expenses |
1,523,000
|
466,000
|
1,003,000 |
| Earnings before taxes |
-20,662,000
|
23,021,000
|
36,121,000 |
| EBITDA |
29,551,000
|
25,717,000
|
37,423,000 |
| Total assets |
270,063,000
|
316,065,000
|
317,093,000 |
| Current assets |
33,759,000
|
31,955,000
|
23,934,000 |
| Current liabilities |
24,951,000
|
20,259,000
|
23,722,000 |
| Equity capital |
211,508,200
|
261,541,700
|
261,702,720 |
| - share capital |
2,054,000
|
2,054,000
|
2,054,000 |
| Employees (average) |
6,875
|
6,814
|
6,633 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
78.3%
|
82.7%
|
82.5% |
| Turnover per employee |
24,035
|
16,740
|
16,174 |
| Profit as a percentage of turnover |
-12.5%
|
20.2%
|
33.7% |
| Return on assets (ROA) |
-7.1%
|
7.4%
|
11.7% |
| Current ratio |
135.3%
|
157.7%
|
100.9% |
| Return on equity (ROE) |
-9.8%
|
8.8%
|
13.8% |
| Change turnover |
51,179,000
|
6,783,000
|
19,811,000 |
| Change turnover % |
45%
|
6%
|
23% |
| Chg. No. of employees |
61
|
181
|
483 |
| Chg. No. of employees % |
1%
|
3%
|
8% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.